ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

TeleVox Takes Patient Relationship Management to the Next Level at HIMSS 24

ORLANDO, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- TeleVox will showcase how its industry-leading omnichannel patient relationship management platforms address all stages of the patient journey to support better outcomes and experiences at HIMSS 24 (booths 5167 and 5678-02), held March 11-15 at the Orange County Convention Center in Orlando.

Show attendees can hear directly from Vijay Verma, Vice President, Product, in a speaking session titled, “Taking Patient Relationships to the Next Level in 2024.” In the talk hosted in the Patient Engagement Theater on Tuesday, March 12 at 12:45 PM, Vijay will explain the current landscape of patient relationship management (PRM), the latest technologies that can be leveraged, and the benefits to health providers and their patients.

“Patient relationship management addresses the full patient journey, focusing on digital front door, appointment management, care programs, and patient marketing,” said Vik Krishnan, President of TeleVox. “Our solutions boost the number of visits and revenue, reduce staff and operational burden, and provide a delightful patient experience.”

In addition to its kiosk in the Patient Engagement 365 area (booth 5678-02), TeleVox will also utilize booth 5167 to showcase its newest technologies:

  • TeleVox’s Enterprise Edition redefines patient engagement, turning episodic interactions into continuous, evolving relationships. Leveraging SMART SMS, this omnichannel solution enhances patient experiences, optimizes care, lightens the staff workload, and contributes to the financial success of health systems.

  • TeleVox’s Practice Edition is a purpose-built variant that meets the unique needs of physician practices. Practice Edition addresses common industry challenges – such as inefficient scheduling, lack of automated and scalable communications, patient retention, and reputation management – further highlighting TeleVox’s dedication to redefining healthcare communication through advanced technologies like SMART SMS.

  • TeleVox’s Iris™ was debuted at HIMSS 23 and is an AI-driven omnichannel virtual assistant, designed to elevate the patient experience. Iris empowers patients to self-serve key tasks such as scheduling appointments, refilling prescriptions, and accessing vital information, including insurance coverage details, seamlessly across SMART SMS, voice, or web interfaces.

For more information about these offerings, please visit TeleVox at booth 5167 at HIMSS 24 or visit www.televox.com.

About TeleVox
TeleVox is a leading provider of omnichannel digital patient relationship management technology. Our solutions are used by more than 7,000 healthcare organizations—from hospitals and health systems to community health centers—to engage, educate, and empower patients throughout their care journey. Our patient relationship management platform integrates with the electronic health record (EHR) to support automated, personalized, two-way interactions with patients. And our pharmaceutical team partners with life science companies to develop strategic disease state awareness, education, and vaccination reminders by reaching more patients through customized communication. All of these exchanges are possible via text, virtual assistant, interactive voice response (IVR), email, and postcards. For 30 years, TeleVox has helped preserve care continuity, reduce the operational burden on staff, and drive revenue while making the healthcare communication process easier for everyone. TeleVox is part of West Technology Group, LLC controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).

Learn more at www.televox.com.

Contact
Donald Thompson
Head of Marketing
Donald.thompson@televox.com
(315) 720-3304


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.